<VariationArchive VariationID="267248" VariationName="NM_001378743.1(CYLD):c.2291_2295del (p.Lys764fs)" VariationType="Deletion" Accession="VCV000267248" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-08" DateCreated="2016-10-23" MostRecentSubmission="2024-03-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="262127" VariationID="267248">
      <GeneList>
        <Gene Symbol="CYLD" FullName="CYLD lysine 63 deubiquitinase" GeneID="1540" HGNC_ID="HGNC:2584" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="50742086" stop="50801935" display_start="50742086" display_stop="50801935" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="50775960" stop="50835845" display_start="50775960" display_stop="50835845" Strand="+" />
          </Location>
          <OMIM>605018</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYLD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYLD">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="CYLD-AS2" FullName="CYLD antisense RNA 2" GeneID="105371251" HGNC_ID="HGNC:56848" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="50783859" stop="50803345" display_start="50783859" display_stop="50803345" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001378743.1(CYLD):c.2291_2295del (p.Lys764fs)</Name>
      <CanonicalSPDI>NC_000016.10:50792643:TAAACTA:TA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="50792644" stop="50792648" display_start="50792644" display_stop="50792648" variantLength="5" positionVCF="50792643" referenceAlleleVCF="TTAAAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="50826555" stop="50826559" display_start="50826555" display_stop="50826559" variantLength="5" positionVCF="50826554" referenceAlleleVCF="TTAAAC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>p.Lys764fs</Name>
      </OtherNameList>
      <ProteinChange>K764fs</ProteinChange>
      <ProteinChange>K761fs</ProteinChange>
      <ProteinChange>K539fs</ProteinChange>
      <ProteinChange>K751fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.50792646_50792650del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.50792646_50792650del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.50826557_50826561del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.50826557_50826561del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012061.1" sequenceAccession="NG_012061" sequenceVersion="1" change="g.55597_55601del">
            <Expression>NG_012061.1:g.55597_55601del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042355.2" sequenceAccession="NM_001042355" sequenceVersion="2" change="c.2282_2286del">
            <Expression>NM_001042355.2:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035814.1" sequenceAccession="NP_001035814" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001035814.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042412.3" sequenceAccession="NM_001042412" sequenceVersion="3" change="c.2282_2286del">
            <Expression>NM_001042412.3:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035877.1" sequenceAccession="NP_001035877" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001035877.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378743.1" sequenceAccession="NM_001378743" sequenceVersion="1" change="c.2291_2295del" MANESelect="true">
            <Expression>NM_001378743.1:c.2291_2295del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365672.1" sequenceAccession="NP_001365672" sequenceVersion="1" change="p.Lys764fs">
            <Expression>NP_001365672.1:p.Lys764fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378744.1" sequenceAccession="NM_001378744" sequenceVersion="1" change="c.2282_2286del">
            <Expression>NM_001378744.1:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365673.1" sequenceAccession="NP_001365673" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001365673.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378745.1" sequenceAccession="NM_001378745" sequenceVersion="1" change="c.2282_2286del">
            <Expression>NM_001378745.1:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365674.1" sequenceAccession="NP_001365674" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001365674.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378746.1" sequenceAccession="NM_001378746" sequenceVersion="1" change="c.2282_2286del">
            <Expression>NM_001378746.1:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365675.1" sequenceAccession="NP_001365675" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001365675.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378747.1" sequenceAccession="NM_001378747" sequenceVersion="1" change="c.2282_2286del">
            <Expression>NM_001378747.1:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365676.1" sequenceAccession="NP_001365676" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001365676.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378748.1" sequenceAccession="NM_001378748" sequenceVersion="1" change="c.2282_2286del">
            <Expression>NM_001378748.1:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365677.1" sequenceAccession="NP_001365677" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001365677.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378749.1" sequenceAccession="NM_001378749" sequenceVersion="1" change="c.2282_2286del">
            <Expression>NM_001378749.1:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365678.1" sequenceAccession="NP_001365678" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001365678.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378750.1" sequenceAccession="NM_001378750" sequenceVersion="1" change="c.2282_2286del">
            <Expression>NM_001378750.1:c.2282_2286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365679.1" sequenceAccession="NP_001365679" sequenceVersion="1" change="p.Lys761fs">
            <Expression>NP_001365679.1:p.Lys761fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378751.1" sequenceAccession="NM_001378751" sequenceVersion="1" change="c.2252_2256del">
            <Expression>NM_001378751.1:c.2252_2256del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365680.1" sequenceAccession="NP_001365680" sequenceVersion="1" change="p.Lys751fs">
            <Expression>NP_001365680.1:p.Lys751fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378752.1" sequenceAccession="NM_001378752" sequenceVersion="1" change="c.2252_2256del">
            <Expression>NM_001378752.1:c.2252_2256del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365681.1" sequenceAccession="NP_001365681" sequenceVersion="1" change="p.Lys751fs">
            <Expression>NP_001365681.1:p.Lys751fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378753.1" sequenceAccession="NM_001378753" sequenceVersion="1" change="c.2252_2256del">
            <Expression>NM_001378753.1:c.2252_2256del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365682.1" sequenceAccession="NP_001365682" sequenceVersion="1" change="p.Lys751fs">
            <Expression>NP_001365682.1:p.Lys751fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378754.1" sequenceAccession="NM_001378754" sequenceVersion="1" change="c.1616_1620del">
            <Expression>NM_001378754.1:c.1616_1620del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365683.1" sequenceAccession="NP_001365683" sequenceVersion="1" change="p.Lys539fs">
            <Expression>NP_001365683.1:p.Lys539fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378755.1" sequenceAccession="NM_001378755" sequenceVersion="1" change="c.1616_1620del">
            <Expression>NM_001378755.1:c.1616_1620del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365684.1" sequenceAccession="NP_001365684" sequenceVersion="1" change="p.Lys539fs">
            <Expression>NP_001365684.1:p.Lys539fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015247.3" sequenceAccession="NM_015247" sequenceVersion="3" change="c.2291_2295del">
            <Expression>NM_015247.3:c.2291_2295del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056062.1" sequenceAccession="NP_056062" sequenceVersion="1" change="p.Lys764fs">
            <Expression>NP_056062.1:p.Lys764fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_166071.1" sequenceAccession="NR_166071" sequenceVersion="1" change="n.2380_2384del">
            <Expression>NR_166071.1:n.2380_2384del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_491" sequenceAccession="LRG_491">
            <Expression>LRG_491:g.55597_55601del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015247.2" sequenceAccession="NM_015247" sequenceVersion="2" change="c.2291_2295delAACTA">
            <Expression>NM_015247.2:c.2291_2295delAACTA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10590085" DB="ClinGen" />
        <XRef Type="rs" ID="886040887" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001378743.1(CYLD):c.2291_2295del (p.Lys764fs) AND Familial cylindromatosis" Accession="RCV000257950" Version="2">
        <ClassifiedConditionList TraitSetID="1455">
          <ClassifiedCondition DB="MedGen" ID="C1851526">Familial cylindromatosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-09-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001378743.1(CYLD):c.2291_2295del (p.Lys764fs) AND multiple conditions" Accession="RCV003988838" Version="1">
        <ClassifiedConditionList TraitSetID="72243">
          <ClassifiedCondition DB="MedGen" ID="C1857941">Brooke-Spiegler syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1851526">Familial cylindromatosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="CN296585">Trichoepithelioma, multiple familial, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-10-23" MostRecentSubmission="2024-03-30">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1455" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1211" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial cylindromatosis</ElementValue>
                <XRef ID="MONDO:0007565" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Turban tumors</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Turban tumor syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ancell-Spiegler cylindromas</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CYLD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CYLD cutaneous syndrome (CCS) typically manifests in the second or third decade with the appearance of multiple skin tumors including cylindromas, spiradenomas, trichoepitheliomas, and rarely, membranous basal cell adenoma of the salivary gland. The first tumor typically develops at puberty and tumors progressively accumulate through adulthood. Females often have more tumors than males. Tumors typically arise on the scalp and face but can also arise on the torso and sun-protected sites, such as the genital and axillary skin. A minority of individuals develop salivary gland tumors. Rarely, pulmonary cylindromas can develop in large airways and compromise breathing. Although the tumors are usually benign, malignant transformation is recognized.</Attribute>
                <XRef ID="NBK555820" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9707" />
                <XRef ID="9707" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32298062</ID>
                <ID Source="BookShelf">NBK555820</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="211" DB="Orphanet" />
              <XRef ID="79493" DB="Orphanet" />
              <XRef ID="C1851526" DB="MedGen" />
              <XRef ID="MONDO:0007565" DB="MONDO" />
              <XRef Type="MIM" ID="132700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="72243" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="540" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Brooke-Spiegler syndrome</ElementValue>
                <XRef ID="MONDO:0011512" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SBS</ElementValue>
                <XRef Type="MIM" ID="605041" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BRSS</ElementValue>
                <XRef Type="MIM" ID="605041" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BSS</ElementValue>
                <XRef Type="MIM" ID="605041" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CYLD cutaneous syndrome (CCS) typically manifests in the second or third decade with the appearance of multiple skin tumors including cylindromas, spiradenomas, trichoepitheliomas, and rarely, membranous basal cell adenoma of the salivary gland. The first tumor typically develops at puberty and tumors progressively accumulate through adulthood. Females often have more tumors than males. Tumors typically arise on the scalp and face but can also arise on the torso and sun-protected sites, such as the genital and axillary skin. A minority of individuals develop salivary gland tumors. Rarely, pulmonary cylindromas can develop in large airways and compromise breathing. Although the tumors are usually benign, malignant transformation is recognized.</Attribute>
                <XRef ID="NBK555820" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10179" />
                <XRef ID="10179" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32298062</ID>
                <ID Source="BookShelf">NBK555820</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="79493" DB="Orphanet" />
              <XRef ID="C1857941" DB="MedGen" />
              <XRef ID="MONDO:0011512" DB="MONDO" />
              <XRef Type="MIM" ID="605041" DB="OMIM" />
            </Trait>
            <Trait ID="1211" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial cylindromatosis</ElementValue>
                <XRef ID="MONDO:0007565" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Turban tumors</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Turban tumor syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ancell-Spiegler cylindromas</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CYLD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CYLD cutaneous syndrome (CCS) typically manifests in the second or third decade with the appearance of multiple skin tumors including cylindromas, spiradenomas, trichoepitheliomas, and rarely, membranous basal cell adenoma of the salivary gland. The first tumor typically develops at puberty and tumors progressively accumulate through adulthood. Females often have more tumors than males. Tumors typically arise on the scalp and face but can also arise on the torso and sun-protected sites, such as the genital and axillary skin. A minority of individuals develop salivary gland tumors. Rarely, pulmonary cylindromas can develop in large airways and compromise breathing. Although the tumors are usually benign, malignant transformation is recognized.</Attribute>
                <XRef ID="NBK555820" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9707" />
                <XRef ID="9707" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32298062</ID>
                <ID Source="BookShelf">NBK555820</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="211" DB="Orphanet" />
              <XRef ID="79493" DB="Orphanet" />
              <XRef ID="C1851526" DB="MedGen" />
              <XRef ID="MONDO:0007565" DB="MONDO" />
              <XRef Type="MIM" ID="132700" DB="OMIM" />
            </Trait>
            <Trait ID="56088" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Trichoepithelioma, multiple familial, 1</ElementValue>
                <XRef ID="CYLD-15" DB="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" />
                <XRef ID="MONDO:0042977" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFT1</ElementValue>
                <XRef Type="MIM" ID="601606" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CYLD cutaneous syndrome (CCS) typically manifests in the second or third decade with the appearance of multiple skin tumors including cylindromas, spiradenomas, trichoepitheliomas, and rarely, membranous basal cell adenoma of the salivary gland. The first tumor typically develops at puberty and tumors progressively accumulate through adulthood. Females often have more tumors than males. Tumors typically arise on the scalp and face but can also arise on the torso and sun-protected sites, such as the genital and axillary skin. A minority of individuals develop salivary gland tumors. Rarely, pulmonary cylindromas can develop in large airways and compromise breathing. Although the tumors are usually benign, malignant transformation is recognized.</Attribute>
                <XRef ID="NBK555820" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32298062</ID>
                <ID Source="BookShelf">NBK555820</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="CN296585" DB="MedGen" />
              <XRef ID="MONDO:0042977" DB="MONDO" />
              <XRef Type="MIM" ID="601606" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="623194" SubmissionDate="2016-10-14" DateLastUpdated="2016-10-23" DateCreated="2016-10-23">
        <ClinVarSubmissionID localKey="CYLD-21|OMIM:132700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000324913" DateUpdated="2016-10-23" DateCreated="2016-10-23" Type="SCV" Version="1" SubmitterName="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" OrgID="165021" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">DGD Variant Analysis Guidelines</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx</URL>
            <CitationText>DGD_Variant_Analysis_Guidelines.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYLD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.[Lys764Ilefs*2]</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015247.2:c.2291_2295delAACTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cylindromatosis, familial</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="132700" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyDescription>Clinical Testing</StudyDescription>
        <Comment>Clinical Testing</Comment>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8985148" SubmissionDate="2024-03-27" DateLastUpdated="2024-03-30" DateCreated="2024-03-30">
        <ClinVarSubmissionID localKey="NM_001378743.1:c.2291_2295del|OMIM:605041;132700;601606" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004805249" DateUpdated="2024-03-30" DateCreated="2024-03-30" Type="SCV" Version="1" SubmitterName="Molecular Genetics and NGS Laboratory, Hospital Fundacion Valle Del Lili" OrgID="509060" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Latin</Ethnicity>
              <GeographicOrigin>Colombia</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYLD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001378743.1:exon 16</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Lys764fs</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="886040887" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001378743.1:c.2291_2295del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605041" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="132700" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601606" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14341956</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="623194" TraitType="Disease" MappingType="Name" MappingValue="Cylindromatosis, familial" MappingRef="Preferred">
        <MedGen CUI="C1851526" Name="Familial cylindromatosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8985148" TraitType="Disease" MappingType="XRef" MappingValue="132700" MappingRef="OMIM">
        <MedGen CUI="C1851526" Name="Familial cylindromatosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8985148" TraitType="Disease" MappingType="XRef" MappingValue="605041" MappingRef="OMIM">
        <MedGen CUI="C1857941" Name="Brooke-Spiegler syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8985148" TraitType="Disease" MappingType="XRef" MappingValue="601606" MappingRef="OMIM">
        <MedGen CUI="CN296585" Name="Trichoepithelioma, multiple familial, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

